局部外膜缓释西罗莫司对内瘘血管内膜增生的影响
Effect of local slow-release coated sirolmus on fistula neointimal hyperplasia

DOI: 10.6040/j.issn.1671-7554.0.2015.1031

Keywords: 结缔组织生长因子,自体动静脉内瘘,内膜增生,西罗莫司,转化生长因子β1,
Cimino-brescia arteriovenous fistula,Intimal hyperplasia,Sirolmus,Transforming growth factor-β1,Connective tissue growth factor

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Kim YO, Choi YJ, Kim JI, et al. The impact of intima-media thickness of radial artery on early failure of radiocephalic arteriovenous fistula in hemodialysis patients[J]. J Korean Med Sci, 2006, 21(2): 284-289.
[2]	Lemos PA, Serruys PW, Van-domburg RT, et al. Unrestricted utilization of sirolmus-eluting stents compared with conventional bare stent implantation in the “real world”: the rapamycin-eluting stent evaluated at rotterdam cardiology hospital(research)registry[J]. Circulation, 2004, 109(2): 190-195.
[3]	Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model[J]. J Clin Invest, 1994, 93(3): 1172-1178.
[4]	Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system[J]. EMBO J, 2000, 19(8): 1745-1754.
[5]	Rossing P. Diabetic nephropathy: Worldwide epidemic and effects of current treatment on natural history[J]. Curr Diab Rep, 2006, 6(6): 479-483.
[6]	Ruygrok PN, Muller DW, Serruys PW. Rapamycin in cardiovascular medicine[J]. Intern Med J, 2003, 33(3): 103-109.
[7]	Yamaji K, Natsuaki M, Morimoto T, et al. Long-term outcomes after coronary stent implantation in patients presenting with versus without acute myocardial infarction(an observation from coronary revascularization demonstrating outcome study-Kyoto registry cohort-2)[J]. Am J Cardiol, 2015, 116(1): 15-23.
[8]	Suzuki N, Angiolillo DJ, Tannenbaum MA, et al. Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial[J]. Catheter Cardiovasc Interv, 2009, 73(7): 890-897.
[9]	Peng YH, Coumar MS, Leou JS, et al. Structural basis for the improved potency of peroxisome proliferator-activated receptor(PPAR)agonists[J]. Chem Med Chem, 2010, 5(10): 1707-1716.
[10]	Yu X, Takayama T, Goel SA, et al. A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia[J]. J Controlled Release, 2014, 191(10): 47-53.
[11]	Dixon BS. Why dont fistulas mature?[J]. Kidney Int, 2006, 70(8): 1413-1422.
[12]	Ikegaya N, Yamamoto T, Takeshita A, et al. Elevated erythropoietin receptor and transforming growth factorβ1 expression in stenotic AV fistulae used for hemodialysis[J]. J Am Soc Nephrol, 2000, 11(5): 928-935.
[13]	Kanzaki T, Tamura K, Takahashi K, et al. In vivo effect of TGF-beta1. Enhanced intimal thickening by administration of TGF-beta 1 in rabbit arteries injured with a balloon catheter[J]. Arterioscler Thromb Vasc Biol, 1995, 15(11): 1951-1957.
[14]	Shi Y, O'Brien JE, Fard A, et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries[J]. Circulation, 1996, 94(7): 1655-1664.
[15]	Liu BC, Li L, Gao M, et al. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis[J]. Chin Med J, 2008, 121(21): 2157-2161.
[16]	Mehilli J, Byrne BA, Wieczorek A, et al. Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis[J]. Eur Heart, 2008, 29(16): 1975-1982.
[17]	Gh K, Mhs M, H R, et al. Primary patency rate of native AV fistula: long term follow up[J]. Int J Clin Exp Med, 2012, 5(2): 173-178.

Full-Text